Publications by authors named "Mayra Ramos"

Claim this Profile
I
Insomnia Symptoms and Self-Regulated Eating Behavior in Hispanic Emerging Adults: An Exploration of Acculturative Stress.
Ainsley A Miller, Pablo Soto, Mayra S Ramos, Spencer A Nielson, Natalie Dautovich

Brain Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Current Status of Phytoseiid Mites as Biological Control Agents in Latin America and Experiences from Argentina Using Neoseiulus californicus.
Carlos Vásquez, Yelitza Coromoto Colmenárez, Nancy Greco, Mayra Ramos

Neotrop Entomol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceived Stress, Religiosity, and Substance Use Among African American and Latinx College Students with Asthma in the USA.
Robin S Everhart, Katherine D Lohr, Mayra S Ramos, Rafael E Hernández Dubon, Kristin E Heron

J Relig Health· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Status of Phytoseiid Mites as Biological Control Agents in Latin America and Experiences from Argentina Using Neoseiulus californicus.
Carlos Vásquez, Yelitza Coromoto Colmenárez, Nancy Greco, Mayra Ramos

Neotrop Entomol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The COVID-19 pandemic: asthma control, tobacco use, and mental health among African American and Latinx college students.
Mayra S Ramos, Rosalie Corona, Katherine W Dempster, Sarah C M Morton, Robin S Everhart

J Asthma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family processes and structure: Longitudinal influences on adolescent disruptive and internalizing behaviors.
Shannon M Savell, Ravjot Saini, Mayra Ramos, Melvin N Wilson, Kathryn Lemery-Chalfant

Fam Relat· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Culturally enhancing a group-based motivational interviewing substance use prevention program for Latine youth.
Oswaldo Moreno, Melissa Avila, Isis Garcia-Rodriguez, Stephanie Romo, Jennifer Rodriguez, Mayra S Ramos

Contemp Clin Trials Commun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody.
Danay Saavedra, Ana L Añé-Kourí, Egda M Llanez Gregorich, Jilma Mena, Patricia Lorenzo-Luaces, Mayra Ramos

Immunol Lett· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario.
Henrry Diaz, Jorge Jiménez, Aray Hernández, Leivis Valdés, Ariadna Martínez, Mayra Ramos

Front Public Health· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases.
Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, Carlos Herrera, Carlos Figueredo, Mayra Ramos

Immunotherapy· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.
Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio Betancourt, Mayra Ramos

Immun Ageing· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
Armando Caballero, Lázaro M Filgueira, Julio Betancourt, Naivy Sánchez, Carlos Hidalgo, Mayra Ramos

Clin Transl Immunology· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nimotuzumab: beyond the EGFR signaling cascade inhibition.
Zaima Mazorra, Lisset Chao, Anabel Lavastida, Belinda Sanchez, Mayra Ramos

Semin Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.
Lucely Cetina, Tania Crombet, Roberto Jiménez-Lima, Sergio Zapata, Mayra Ramos

Cancer Biol Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.
Pedro C Rodriguez, Roberto Torres-Moya, Gil Reyes, Claudino Molinero, Dinorah Prada, Mayra Ramos

Results Immunol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leakage into Portuguese aquatic environments of extended-spectrum-beta-lactamase-producing Enterobacteriaceae.
Elisabete Machado, Teresa M Coque, Rafael Cantón, João Carlos Sousa, Diana Silva, Mayra Ramos

J Antimicrob Chemother· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188 Re in adult recurrent high-grade glioma.
Angel Casacó, Gerardo López, Iván García, José Arsenio Rodríguez, Ramsés Fernández, Mayra Ramos

Cancer Biol Ther· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic and skin toxicity in Cercopithecus aethiops sabaeus monkeys treated during 26 weeks with a high intravenous dose of the anti- epidermal growth factor receptor monoclonal antibody Nimotuzumab.
Maria Elene Arteaga, Nuris Ledón, Angel Casacó, Balia Pardo, Miriam García, Mayra Ramos

Cancer Biol Ther· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: report from a phase I/II trial.
Tania Crombet Ramos, Javier Figueredo, Mauricio Catala, Sandra González, Julio C Selva, Mayra Ramos

Cancer Biol Ther· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II clinical trial of the humanized anti-EGF-r monoclonal antibody h-R3 labelled with 99mTc in patients with tumour of epithelial origin.
Leonel A Torres, Alejandro Perera, Juan F Batista, Abel Hernández, Tania Crombet, Mayra Ramos

Nucl Med Commun· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiology of liver cirrhosis in Mexico.
Nahum Méndez-Sánchez, Juan R Aguilar-Ramírez, Angel Reyes, Margarita Dehesa, Alberto Juórez, Mayra Ramos

Ann Hepatol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.
Tania Crombet, Marta Osorio, Teresa Cruz, Carlos Roca, Ramón del Castillo, Mayra Ramos

J Clin Oncol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis